<--- Back to Details
First PageDocument Content
Chemistry / Research / Amines / Cyclopropanes / Milnacipran / Fibromyalgia / European Medicines Agency / Committee for Medicinal Products for Human Use / Electronic patient-reported outcome / Health / Clinical research / Serotonin-norepinephrine reuptake inhibitors
Date: 2013-07-21 06:02:42
Chemistry
Research
Amines
Cyclopropanes
Milnacipran
Fibromyalgia
European Medicines Agency
Committee for Medicinal Products for Human Use
Electronic patient-reported outcome
Health
Clinical research
Serotonin-norepinephrine reuptake inhibitors

Add to Reading List

Source URL: www.ema.europa.eu

Download Document from Source Website

File Size: 40,85 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document